Who Paid My Doc
Eric Sickinger
Neuromusculoskeletal Medicine, Sports Medicine San Clemente, CA Doctor of Osteopathy
NPI 1215367792 CMS profile 540037
665 Camino De Los Mares Ste 305, San Clemente, CA 92673
General payments
$11,538
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Eric Sickinger of San Clemente, CA is reported in the CMS Open Payments database as having received $11,538 across 160 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 93rd percentile of Neuromusculoskeletal Medicine, Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,618 | 23 | |
| 2024 | General | $1,194 | 16 | |
| 2023 | General | $1,162 | 14 | |
| 2022 | General | $1,362 | 17 | |
| 2021 | General | $1,672 | 34 | |
| 2020 | General | $1,320 | 31 | |
| 2019 | General | $3,212 | 25 |
Beside peers
- Eric Sickinger
- Neuromusculoskeletal Medicine, Sports Medicine median
- Middle half of Neuromusculoskeletal Medicine, Sports Medicine
- National median
In program year 2025, general payments to Eric Sickinger were reported at $1,618. Among 69 Neuromusculoskeletal Medicine, Sports Medicine profiles paid that year, the median was $125 and the middle half received between $37 and $473.
Show as a table
| Year | Eric Sickinger | Neuromusculoskeletal Medicine, Sports Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,212 | $152 | $43–$474 | $163 |
| 2020 | $1,320 | $113 | $31–$725 | $114 |
| 2021 | $1,672 | $167 | $50–$469 | $132 |
| 2022 | $1,362 | $132 | $46–$572 | $149 |
| 2023 | $1,162 | $109 | $39–$366 | $160 |
| 2024 | $1,194 | $115 | $37–$321 | $164 |
| 2025 | $1,618 | $125 | $37–$473 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 19 billing codesPaid by Medicare
$75,947
Medicare patients
226
Services billed
1,338
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 75% | |
| High blood pressure | 61% | |
| Ischemic heart disease | 24% | |
| Osteoporosis | 22% | |
| Cancer | 19% | |
| Diabetes | 18% | |
| Atrial fibrillation | 16% | |
| Chronic kidney disease | 15% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose J7321 | Office | 21 | 117 | $6,689 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 66 | 363 | $273 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
1 product · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| AMELUZ |
|
$11 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
160 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neuromusculoskeletal Medicine, Sports Medicine in California
George Tang
Neuromusculoskeletal Medicine, Sports Medicine · Pasadena, CA
Vahe Panossian
Neuromusculoskeletal Medicine, Sports Medicine · Pasadena, CA
Chin Kim
Neuromusculoskeletal Medicine, Sports Medicine · Anaheim, CA
Harold Jackson
Neuromusculoskeletal Medicine, Sports Medicine · Sacramento, CA
Yigit Karasozen
Neuromusculoskeletal Medicine, Sports Medicine · Los Angeles, CA
Thomas Reece
Neuromusculoskeletal Medicine, Sports Medicine · San Rafael, CA
Related records
Neuromusculoskeletal Medicine, Sports Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Neuromusculoskeletal Medicine, Sports Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.